• OPEN AN ACCOUNT
Indian Indices
Nifty
25,103.20 100.15
(0.40%)
Sensex
82,445.21 256.22
( 0.31%)
Bank Nifty
56,839.60 261.20
( 0.46%)
Nifty IT
37,669.20 374.35
( 1.00%)
Global Indices
Nasdaq
42,779.54 438.80
(1.04%)
Dow Jones
6,020.48 60.18
(1.01%)
Hang Seng
38,084.54 342.93
(0.91%)
Nikkei 225
8,832.28 -5.63
(-0.06%)
Forex
USD-INR
85.77 -0.09
(-0.10%)
EUR-INR
97.89 0.03
(0.03%)
GBP-INR
116.15 -0.09
(-0.08%)
JPY-INR
0.59 0.00
(-0.69%)

EQUITY - MARKET SCREENER

Mahindra Lifespace Developers Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
532313
INE813A01018
143.0581205
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MAHLIFE
140.08
7199.86
EPS(TTM)
Face Value()
Div & Yield %
2.41
10
0.6
 

expo engineering & projects ltd
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
May 29,2025
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.

For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales2246.692033.03 11 8939.597705.04 16
OPM %19.0915.83 -19.3117.15 -
PBDT433.17311.45 39 1734.011307.66 33
PBT333.05213.32 56 1336.19950.42 41
NP67.8259.59 14 737.68547.35 35